Concourse Financial Group Securities, Inc. Bright Minds Biosciences Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.41 - $0.7 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.41 - $0.87 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.74 - $6.0 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.75 - $6.5 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.8 - $1.57 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.44 - $3.37 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$3.17 - $8.23 $0 - $0
0 New
0 $0

About BRIGHT MINDS BIOSCIENCES INC.

DRUG Quotes by TradingView
  • Ticker DRUG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,209,900
  • Market Cap $640M
  • Description
  • Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collabor...
More about DRUG
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email